Literature DB >> 9195058

Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons.

C R MacIntyre1, N Kendig, L Kummer, S Birago, N M Graham.   

Abstract

Our aim was to determine the incidence of tuberculin skin test (TST) conversion in the Maryland state correctional system. We conducted a historical longitudinal cohort study. A sample of 1,289 inmates, incarcerated in 16 of 23 prisons, who had a negative TST and a second test within 24 months was selected. The incidence of recent conversion was 6.3 per 100 person-years. Risk factors for conversion included high prison-population density (relative risk [RR] = 2.4; 95% confidence interval [CI], 1.5-3.8) and incarceration in a higher-security institution (RR = 2.4; 95% CI, 1.4-4.3). Incarceration in an institution with higher levels of isoniazid prophylaxis (> 65% of TST positives) reduced the risk of infection by 50% (RR = 0.5; 95% CI, 0.3-0.7). Crowding was strongly correlated with risk of conversion (r = 0.83; P < .001), while rates of isoniazid prophylaxis initiation were inversely correlated with risk of infection (r = -0.82; P < .001). In stepwise regression, higher prison-population density was the strongest predictor of increased infection. In a final model, inclusion of the rate of isoniazid prophylaxis initiation reduced the risk associated with crowding (RR = 1.4; P = .4). Annual screening programs for prisons can identify recent conversions that may not otherwise be detected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195058     DOI: 10.1086/513632

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

Review 1.  Tuberculosis in prisons in countries with high prevalence.

Authors:  R Coninx; D Maher; H Reyes; M Grzemska
Journal:  BMJ       Date:  2000-02-12

2.  Prisons as social determinants of hepatitis C virus and tuberculosis infections.

Authors:  Niyi Awofeso
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

3.  Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.

Authors:  Ted Cohen; Caroline Colijn; Bryson Finklea; Megan Murray
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

Review 4.  Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.

Authors:  Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

5.  High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons.

Authors:  Kristine M Schmit; Mark N Lobato; Simona G Lang; Sherri Wheeler; Newton E Kendig; Sarah Bur
Journal:  J Public Health Manag Pract       Date:  2019 Mar/Apr

6.  Unrecognised transmission of tuberculosis in prisons.

Authors:  C R MacIntyre; N Kendig; L Kummer; S Birago; N M Graham; A J Plant
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

7.  Assessment of tuberculosis screening and management practices of large jail systems.

Authors:  Audrey A Reichard; Mark N Lobato; Cheryl A Roberts; Lauri B Bazerman; Theodore M Hammett
Journal:  Public Health Rep       Date:  2003 Nov-Dec       Impact factor: 2.792

Review 8.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Authors:  Christopher S Kovacs; Christine E Koval; David van Duin; Amanda Guedes de Morais; Blanca E Gonzalez; Robin K Avery; Steven D Mawhorter; Kyle D Brizendine; Eric D Cober; Cyndee Miranda; Rabin K Shrestha; Lucileia Teixeira; Sherif B Mossad
Journal:  World J Transplant       Date:  2014-06-24

9.  Can social history variables predict prison inmates' risk for latent tuberculosis infection?

Authors:  Tyler E Weant; Abigail Norris Turner; Maureen Murphy-Weiss; David M Murray; Shu-Hua Wang
Journal:  Tuberc Res Treat       Date:  2012-12-23

10.  Risk factors for tuberculosis.

Authors:  Padmanesan Narasimhan; James Wood; Chandini Raina Macintyre; Dilip Mathai
Journal:  Pulm Med       Date:  2013-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.